ArticlePharmaceuticals (Basel, Switzerland)2023

Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin.

Svetlana Paskas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.